✦ LIBER ✦

An exciting candidate therapy for sepsis: ulinastatin, a urinary protease inhibitor

✍ Scribed by Adam Linder,James A. Russell

Book ID: 126341974
Publisher: Springer
Year: 2014
Tongue: English
Weight: 159 KB
Volume: 40
Category: Article
ISSN: 1432-1238
DOI: 10.1007/s00134-014-3366-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ulinastatin is a novel candidate drug fo

Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model

✍ Wang, Ning; Liu, Xin; Zheng, Xinchuan; Cao, Hongwei; Wei, Guo; Zhu, Yuanfeng; Fa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 788 KB

A hybrid protein comprising ATF domain o

A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy

✍ Qiming Sun; Qian Xu; Xiangbai Dong; Lin Cao; Xiaofeng Huang; Qingang Hu; Zi-Chun 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 693 KB

## Abstract Directional and controllable degradation of extracellular matrix mediated by the uPA‐uPA receptor (uPAR) system is ubiquitously implicated in tumor establishment, invasion and metastasis. Targeting the excessive activation of this system as well as the proliferation of the tumor vascula

[Methods and Principles in Medicinal Che

[Methods and Principles in Medicinal Chemistry] Aspartic Acid Proteases as Therapeutic Targets (GHOSH:PROTEASES DRUG TARG O-BK) || The Discovery of β-Secretase and Development toward a Clinical Inhibitor for AD: An Exciting Academic Collaboration

✍ Ghosh, Arun K. 📂 Article 📅 2011 🏛 Wiley-VCH Verlag GmbH & Co. KGaA ⚖ 509 KB